Here is the problem with that analogy. He is using his FB

New Post Public Reply Private Reply Replies (1) Message Board
hylander Zolis_onkel #35017
447
Here is the problem with that analogy. He is using his FB page to criticize the vaccines and Covid and he has mentioned things he has said his company has worked on in the past. He's included his Dubai trip.

Another problem is he is the CEO of a company many are saying is under investigation and he has some sort of gag order. He should as the CEO know how delicate of a situation all of this is and instead, he talks about the vaccines, etc..

I was a manager over many project managers at one time. I also know I represented the company I worked for, so off hours I had to still be careful what I said as it could be misconstrued and could cause issues for said company and the company had policies in place to ensure we were held to such standards. Image is everything. So, Joe is the CEO, yet this does not apply to him or if he is under some gag order, it does not apply to him to talk about vaccines or issues that also correspond to work that could impact NuGenerex based on comments he makes on his FB page yet people keep asking for updates but we just get I feel the same way or we will update you when we can which has gone on for 7 or so months.

These are issues I have and I am just a small fish in a big pond, it does bother me especially when I don't see anything positive happening with either Generex or NuGenerex and to be honest, based off of every PR and every CC, we should have been on NASDAQ and should be seeing deals coming through with Covid or no Covid by now.

Anyways, we all can speculate on anything. Only Joe and a few others know for sure what is going on and they are not talking. So, we all can guess and be ok with it or be frustrated. Right now, it's basically to late to do anything, so either Joe has moved on to his next endeavor or we are waiting for the next miracle to happen for this company. Time will tell for everyone.

Generex Biotechnology Corp. (GNBTQ) Stock Research Links

GNBTQ Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Vanity Fair Lingerie Reveals New Smoothing Bra

Updated Category News Views 91

A Bra Revolution or Just Another Launch? I'll admit it, lingerie isn't the usual breakfast discussion for me, but Vanity Fair Lingerie's move with their new Flawlessly Smooth™ Bra piqued my interest. Announced in Bowling Green, Kentucky, on November 2, 2026, and set against the lavish backdrop of an upcoming New York City event cohosted by Cosmopolitan, it's less about...

Continue Reading
Extreme Weather Survivors Rally for Change with 'Stolen Summers'

Updated Category News Views 70

Lighting a Fire Under Complacency Elections often bring out the big dogs, but rarely do you see a grassroots campaign like Extreme Weather Survivors’ 'Stolen Summers' making such ripples. Rallying from New York to North Carolina and everywhere in between, this campaign has been a clarion call for communities ravaged by Mother Nature's fury. And let's face it, the...

Continue Reading
Steven Johnson Boosts Latham's Tax Team in D.C.

Updated Category News Views 120

Another Day, Another Big Hire in D.C. You'd think the revolving doors at these law firms were tied to Wall Street's cycles. Latham & Watkins, one heavyweight in the legal arena, is pulling a classic power move, snapping up Steven Johnson for their Washington, D.C. office. He ain't just some guy off the street; Johnson's got a résumé that reads like a textbook on federal...

Continue Reading
XPENG Eyes South Korea Entry with Industry Veteran

Updated Category News Views 120

A Veteran's Task in a New Territory Piling onto its international ambitions, XPENG has roped in Lee Man-sik, a seasoned auto industry professional, to break into South Korea. South Korea isn’t just another market—it’s one of the toughest stages for the automotive industry. The customers there are sharp, with a keen eye for tech and quality. So XPENG, trading under...

Continue Reading
TETRA Hits High Mark with Robust Q3 Earnings Surge

Updated Category News Views 98

Financial Milestones and Market Insights Boy, if you're not watching TETRA Technologies (NYSE:TTI) right now, you're probably missing out on a real barnstormer of a financial report. The numbers are looking chalkboards-be-damned stellar! They’ve just notched their finest third quarter in a decade, bringing in revenues through the roof at $168 million—an impressive 10%...

Continue Reading
Protalix to Reveal Q3 2026 Results Amid Rare Disease Push

Updated Category News Views 49

Looking Ahead to Protalix's Q3 Revelation Nobody's pretending it's a cakewalk to stay ahead in the biopharma sector, especially when you're tangoing with the unpredictable world of rare disease therapeutics. But here we are, with Protalix BioTherapeutics scheduling their third-quarter financial results announcement for November 10, 2026. If you've been tracking them—or...

Continue Reading
Boston Scientific's SIMPLAAFY Trial Promises Post-Op Ease

Updated Category News Views 137

SIMPLAAFY Trial Makes Waves in Cardiac Care Alright, let's dig into the heart of the matter—pun fully intended. Boston Scientific (NYSE:BSX) just rolled out some head-turning results from their SIMPLAAFY study, which evaluates the WATCHMAN FLX™ Pro Left Atrial Appendage Closure Device. What’s so special, you ask? Well, it’s all about simplifying the post-surgery...

Continue Reading
MIAX Preps New Binary Options Amid SEC Filings

Updated Category News Views 50

MIAX's Strategic Move Towards Binary Options Ah, that's something that might just shake things up a bit. On November 3rd, 2026, MIAMI International Holdings (NYSE: MIAX) made the headlines by filing with the SEC to offer cash-settled binary index options. Now, if you're not new to the trading game, you know that anything involving SEC registration gets the blood pumping....

Continue Reading
Differentia Bio's AI: Transforming Drug Development Dynamics

Updated Category News Views 28

The Future of Drug Development: AI's New Role When it comes to pharmaceutical R&D, Some outfits are playing pin the tail on the donkey, but Differentia Bio over here is sharpening the pin with some futuristic gadgetry. Yep, they're jazzing up the game with AI-powered digital twins, building lifelike disease environments that predict therapeutic outcomes with precision...

Continue Reading
Platinum Equity's Bold Move on Warren Valve: An Analysis

Updated Category News Views 127

A Big Play in the Valve Game Straight out of the industrial playbook, Platinum Equity swoops in with its latest acquisition of Warren Valve, yanking it from the clutches of Allied Group. It's not every day you see a move like this in the flow control world. Yeah, you heard that right—flow control. The kind of business that’s all about ensuring the right stuff gets to...

Continue Reading

Top 5 Most Recently Viewed Articles

BOXX Insurance Expands in the US with Key Leadership Additions

Updated Category News Views 267

BOXX Insurance Embraces Growth in the U.S. Market BOXX Insurance is strategically enhancing its footprint in the U.S. market by appointing key leadership positions aimed at innovation within the cyber insurance space. This forward-thinking global insurtech is committed to delivering unique solutions tailored for both businesses and consumers. The expansion signifies a...

Continue Reading
Celleste Bio™ Innovates Production of Eco-Friendly Cocoa Butter

Updated Category News Views 234

Celleste Bio™ Achieves Landmark Cocoa Butter Production Celleste Bio™, an innovative cocoa technology company, has proudly announced a groundbreaking milestone in transforming the cocoa supply chain. The firm has unveiled its first-ever chocolate grade cocoa butter produced using cutting-edge plant cell culture technology, making waves in the agro-technological...

Continue Reading
Understanding VINCI's Share Capital and Voting Rights Total

Updated Category News Views 167

Understanding VINCI's Share Capital and Voting Rights Total VINCI, a prominent French public limited company, is recognized for its significant role in infrastructure and construction. With a robust share capital totaling €1,474,737,915.00, the company's extensive operational framework has positioned it as a leader in its sector. Share Structure Overview As of the...

Continue Reading
Rezolve Ai's Daniel Wagner Advocates for UK AI Advancement

Updated Category News Views 248

Rezolve Ai's Daniel Wagner Advocates for UK AI Advancement In a significant announcement, Daniel Wagner, CEO and founder of Rezolve Ai (NASDAQ: RZLV), expressed strong support for the UK government's initiative to establish a National Data Library. This decision aims to enhance access to high-quality data for developers, a move Wagner characterizes as a pivotal moment for...

Continue Reading
Exploring the Intersection of Art and Technology at Biennale

Updated Category News Views 268

Future Innovations in Art and Technology The China (Hangzhou) Art and Technology Biennale recently launched at the Yuhang Art Museum, serving as a significant platform for cultural exchange and artistic expression. This remarkable event, organized by the China Academy of Art (CAA) along with various art institutions and governmental bodies, showcases a diverse range of...

Continue Reading